Speakers & Moderators

  

Andrea K. Brunson. Andrea K. Brunson, Pfizer, USA
Andrea K. Brunson began her Pfizer career in September, 2003, as logistics engineer in Pfizer’s US Market Logistics group in Memphis, TN. She is currently Senior Manager of the Planning team with America’s Market logistics group. Andrea earned a Bachelor of Science in Mechanical Engineering degree in 1999 from The University of Wisconsin. Prior to joining Pfizer, Andrea worked for a leading consulting firm specializing in Retail Distribution. She currently lives in Collierville, Tennessee
Geoff Power, Packaging Security Specialist, Former Director of Packaging Security, GlaxoSmithKline, UK
Geoff has some 35 years’ experience in Packaging Technology, including 22 years with GlaxoSmithKline. Geoff recently retired as Director of Packaging Security for GSK where he provided a packaging support service to the GSK group world-wide. His responsibilities included maintaining the security and integrity of healthcare packaging operations, and developing a corporate protective strategy against counterfeiting and adulteration. He set up a centralised forensic examination service for suspect packs, and was responsible for developing anti-counterfeit measures. Geoff was Technical Advisor to the Pharmaceutical Security Institute, and authored a technology briefing paper for WHO IMPACT.
 
Andrew John Charvill. Andrew John Charvill, Analytical Assessor, Medicines Testing Scheme, MHRA, UK
Andy Charvill is a chemist by training and has worked at the Medicines and Healthcare products Regulatory Agency (MHRA, the UK Competent Authority) as the Analytical Assessor for the Medicines Testing Scheme (MTS), since 1994. Prior to this Andy was employed in a variety of Quality Control/Quality Assurance positions in the Pharmaceutical Industry, principally in the manufacture of Large Volume Parenterals.
 
Roberto Rosito. Roberto Rosito, Essex Animal Health Friesoythe, Germany
Roberto Rosito has more than 20 years experience in pharmaceutical production. He worked at Hoechst’s subsidiary pharmaceutical plant in Guatemala City and for Twardy’s packaging plant near Cologne. Since 2003 he has been working as Project Manager at Essex Animal Health Friesoythe a Division of Essex Pharma GmbH, responsible for installation and operational qualification projects, conceptual design of equipments and process optimization.
Dr Domenico Di Giorgio. Dr Domenico Di Giorgio, Senior Chemist Officer, Anti-counterfeiting Activities Manager Agenzia Italiana del Farmaco, Roma, Italy
Dr. Di Giorgio is coordinator and member of the organizing committee of the AIFA-WHO international conference “Combating Counterfeit Drugs” (Rome, 2006); Italian member of IMPACT, and Chairman of the EDQM/CoE “Committee of experts on minimising public health risks posed by counterfeiting of medical products and related crimes”.
 
Michael S. Russo. Michael S. Russo, Eli Lilly & Company, USA
Michael S. Russo joined Lilly in 1997. He is a global security manager for Eli Lilly and Company based in Indianapolis, Indiana USA. He is responsible for the management of Lilly’s Global Product Protection Security Team which includes eight (8) experienced investigators based in Asia, Europe and the US who handle cases involving counterfeit, stolen and diverted pharmaceuticals. His responsibilities also extend to general security support for Lilly affiliates outside the United States.
Michaela Hähn, GS1 Germany GmbH, Cologne, Germany
Michaela Hähn joined GS1 Germany, the German EAN organisation, in 1998. She is currently Senior Project Manager AIDC (Automatic Identification and Data Capture).Responsible for the development of new AIDC standards, Michaela is engaged in work on anti-counterfeiting concepts, as well as GS1 Healthcare, the global initiative of GS1 and the healthcare industry to improve patient safety.
 
Dr Stephan Schwarze. Dr. Stephan Schwarze, Bayer Schering Pharma AG, Berlin, Germany
Stephan Schwarze started his career at Schering AG Berlin in 1992 and is now heading the function Counterfeit Protection Management since 2005. First within Schering AG Berlin and nowadays within Bayer Schering Pharma AG. He is a member of WHO IMPACT‘s Technology Subgroup as well as of EFPIA‘s Anti-Counterfeiting ad hoc working group.
Prof Dr Ulrike Holzgrabe. Prof Dr Ulrike Holzgrabe, University of Würzburg, Würzburg, Germany
Ulrike Holzgrabe holds a chair in Pharmaceutical Chemistry at the University of Würzburg and is a member of several national an international committees dealing with the German and European Pharmacopoeia. Thus, she is interested in modern analytical methods for quality assurance of drugs.
 
Prof Dr Klaus-Jürgen Steffens. Prof Dr Klaus-Jürgen Steffens, University of Bonn, Germany
Klaus-J. Steffens holds a chair in Pharmaceutical Technology at the University of Bonn. He is an expert in the development and production of solid dosage forms. The physicochemical characterization of raw materials and final products is one of his most important research fields with more than 20 years experience in special analytical tools, among them spectroscopic methods like NIRS and XRD. /td>
Karl Metzger. Karl Metzger, Welding GmbH & Co. KG, Hamburg, Germany
Karl Metzger works with Welding GmbH & Co. KG in Hamburg as Management responsible for the company’s integrated Management System and is deputy QP for APIs and coordinates Welding’s auditing activities. He is member of FECC’s’Good Trade and Distribution Committee’. Furthermore Karl is APIC certified ICH Q7 Auditor and has more than 10 years experience in global auditing of chemical, biotechnological and pharmaceutical manufacturers.
 
Harald Vogt. Harald Vogt, Senior Researcher, SAP AG, Karlsruhe, Germany
Harald Vogt holds a degree in computer science and is technical project manager for SToP at SAP Research. He has experience in the areas of security, RFID, and ubiquitous computing.
Dr Chris Oldenhof. Dr Chris Oldenhof, DSM Anti-Infectives, Delft, The Netherlands
Chris Oldenhof holds a Ph.D. in organic chemistry. He is currently Manager External Regulatory Affairs at DSM Anti-Infectives, Delft, The Netherlands. In his 29 years with DSM he has held positions in R&D, Marketing & Sales and Regulatory Affairs. Within CEFIC (the European Chemical Industry Council) he is President of APIC (Active Pharmaceutical Ingredients Committee) and a Board Member of the EFCG (European Fine Chemicals Group). In addition he is a member of the Council of Europe’s ad hoc Group on Counterfeit Medicines since 2003.
 
Dr Martin Wesch. Dr Martin Wesch, Lawyer at Wesch & Buchenroth, Stuttgart, Germany
Dr Martin Wesch is a lawyer specialising in medical and industrial law and working for the Stuttgart-based firm of lawyers Wesch & Buchenroth, which he founded in 2001. Since April 2002, he has been teaching industrial law at the University of Stuttgart. Since 1994, Martin Wesch is Managing Director of the Gütegemeinschaft Pharma-Verpackung e.V., a quality association for pharmaceutical packaging.

 
[ imprint ]